Métodos y kits para el pronóstico del cáncer colorrectal

摘要

The invention relates to the methods for predicting the risk of relapse for patients who have colorectal cancer, and to the methods for providing said patients with personalised medicine, based on the expression levels of the genes ACSL1, ACSL4, GCNT3, LPL, APOC1 and SCD, the expression products of which are involved in cellular energy metabolism. The invention also relates to the kits for carrying out the predictive methods and the methods for providing predictive medicine.